CLCS

 
Common Stock SEC Reporting - Delinquent
OTC Pink No Information
Verified Company Profile 11/01/2017
Contact Info
  • 5 Kineret Street
  • Bnei Brak 5126237
  • Israel

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Sep 30, 2016 10-Q
CIK 0001569340
Fiscal Year End 12/31
OTC Marketplace OTC Pink No Information
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: NV, USA
Year of Inc. 2012
Employees 50 a/o Apr 28, 2015
Company Officers/Contacts
Itamar Shimrat President, CEO, CFO
Company Directors
Dennis Brown Chairman
Yoram Drucker
Ben Friedman
Itamar Shimrat
David Zolty
Company Notes
  • Formerly=Ticket To See Inc. until 6-2014
Service Providers
Accounting/Auditing Firm
Marcum LLP
750 Third Ave
11th Floor
New York, NY, 10017
United States

Legal Counsel
Sichenzia Ross Ference Kesner LLP
1185 Avenue of the Americas
37th Floor
New York, NY, 10036
United States

Investor Relations Firm
Not Available
CLCS Security Details
Share Structure
Market Value1 $6,107,314 a/o Dec 13, 2017
Authorized Shares 200,000,000 a/o Sep 30, 2016
Outstanding Shares 24,429,256 a/o Nov 15, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 5,620,428 a/o Apr 20, 2016
Par Value 0.001
Transfer Agent(s) Verified by Transfer Agent
Globex Transfer, LLC
Shareholders
Shareholders of Record 76 a/o Apr 20, 2016
Short Selling Data
Short Interest 754 (100%)
Jun 30, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security